相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Measures of Social and Occupational Function in Early Psychosis: A Systematic Review and Meta-analysis
Megan Cowman et al.
SCHIZOPHRENIA BULLETIN (2023)
It ConTparat1v ruecfs �of l i n ipsychotics on eiglt am an & rho;d' Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis
Michel Sabe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2023)
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials
Hui Wu et al.
SCHIZOPHRENIA BULLETIN (2022)
Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
J. Vazquez-Bourgon et al.
EUROPEAN PSYCHIATRY (2022)
Metabolic syndrome following a first episode of psychosis: results of a 1-year longitudinal study conducted in metropolitan Lisbon, Portugal
Ricardo Coentre et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art
Philip D. Harvey et al.
SCHIZOPHRENIA RESEARCH-COGNITION (2022)
Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
Maarten Bak et al.
PLOS ONE (2021)
Prevalence of Overweight and Obesity in People With Severe Mental Illness: Systematic Review and Meta-Analysis
Medhia Afzal et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
Heidi Taipale et al.
WORLD PSYCHIATRY (2020)
Changes in serum thyroid hormone levels in psychiatric patients treated with second-generation antipsychotics
Jia-Xuan Zhang et al.
ENDOKRYNOLOGIA POLSKA (2020)
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients
Javier Vazquez-Bourgon et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Antipsychotics and glucose metabolism: how brain and body collide
Chantel Kowakhuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
DIABETIC KETOACIDOSIS ASSOCIATED WITH ANTIPSYCHOTIC DRUGS: CASE REPORTS AND A REVIEW OF LITERATURE
Antonia Vuk et al.
PSYCHIATRIA DANUBINA (2017)
Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis
Blazej Misiak et al.
SCHIZOPHRENIA RESEARCH (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014
Joseph F. Hayes et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
Cenk Tek et al.
EARLY INTERVENTION IN PSYCHIATRY (2016)
Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2016)
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
P. Manu et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Fitting Linear Mixed-Effects Models Using lme4
Douglas Bates et al.
JOURNAL OF STATISTICAL SOFTWARE (2015)
Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors
Rocio Perez-Iglesias et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naive Patients
Celso Arango et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2014)
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Maarten Bak et al.
PLOS ONE (2014)
Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
Jian-Ping Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database
Chris J. Bushe et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden
Merete Nordentoft et al.
PLOS ONE (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
Debra L. Foley et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Thyroid Adverse Effects of Psychotropic Drugs: A Review
Rami Bou Khalil et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Mortality in schizophrenia: a measurable clinical endpoint
Chris J. Bushe et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Weight gain in antipsychotic-naive patients: a review and meta-analysis
I. Tarricone et al.
PSYCHOLOGICAL MEDICINE (2010)
Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder
Thomas Munk Laursen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis
Swapna Verma et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2009)
Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors
Amy M. Kilbourne et al.
GENERAL HOSPITAL PSYCHIATRY (2009)
Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
Stefan Gebhardt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
Jayendra K. Patel et al.
SCHIZOPHRENIA RESEARCH (2009)
A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders
Benno Graf Schimmelmann et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
Quetiapine and long-term weight change: A comprehensive data review of patients with schizophrenia
Martin Brecher et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol
RB Zipursky et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial
N Schooler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
The effects of antipsychotic therapy on serum lipids: a comprehensive review
JM Meyer et al.
SCHIZOPHRENIA RESEARCH (2004)
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol
JA Lieberman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Weight gain in first-episode psychosis
J Addington et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2003)
Body mass index in persons with schizophrenia
S Coodin
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2001)
Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia
BJ Kinon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
分享论文
